311 related articles for article (PubMed ID: 25856691)
1. The role of circulating microRNAs as novel biomarkers in diagnosing colorectal cancer: a meta-analysis.
Rokkas T; Kothonas F; Rokka A; Koukoulis G; Symvoulakis E
Eur J Gastroenterol Hepatol; 2015 Jul; 27(7):819-25. PubMed ID: 25856691
[TBL] [Abstract][Full Text] [Related]
2. Predictive power of circulating miRNAs in detecting colorectal cancer.
Zeng W; Tu Y; Zhu Y; Wang Z; Li C; Lao L; Wu G
Tumour Biol; 2015 Apr; 36(4):2559-67. PubMed ID: 25527153
[TBL] [Abstract][Full Text] [Related]
3. Circulating microRNAs as a novel class of diagnostic biomarkers in gastrointestinal tumors detection: a meta-analysis based on 42 articles.
Wang R; Wen H; Xu Y; Chen Q; Luo Y; Lin Y; Luo Y; Xu A
PLoS One; 2014; 9(11):e113401. PubMed ID: 25406082
[TBL] [Abstract][Full Text] [Related]
4. Clinical potential role of circulating microRNAs in early diagnosis of colorectal cancer patients.
Du M; Liu S; Gu D; Wang Q; Zhu L; Kang M; Shi D; Chu H; Tong N; Chen J; Adams TS; Zhang Z; Wang M
Carcinogenesis; 2014 Dec; 35(12):2723-30. PubMed ID: 25239640
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of circulating miR-21 for colorectal cancer: a meta-analysis.
Shan L; Ji Q; Cheng G; Xia J; Liu D; Wu C; Zhu B; Ding Y
Cancer Biomark; 2015; 15(1):47-56. PubMed ID: 25524942
[TBL] [Abstract][Full Text] [Related]
6. Blood-based microRNAs as biomarkers for the diagnosis of colorectal cancer: a systematic review and meta-analysis.
Carter JV; Galbraith NJ; Yang D; Burton JF; Walker SP; Galandiuk S
Br J Cancer; 2017 Mar; 116(6):762-774. PubMed ID: 28152545
[TBL] [Abstract][Full Text] [Related]
7. The accuracy of circulating microRNA-21 in the diagnosis of colorectal cancer: a systematic review and meta-analysis.
Xu F; Xu L; Wang M; An G; Feng G
Colorectal Dis; 2015 May; 17(5):O100-7. PubMed ID: 25683351
[TBL] [Abstract][Full Text] [Related]
8. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer.
Huang Z; Huang D; Ni S; Peng Z; Sheng W; Du X
Int J Cancer; 2010 Jul; 127(1):118-26. PubMed ID: 19876917
[TBL] [Abstract][Full Text] [Related]
9. A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: a systematic review and meta-analysis.
Zhang L; Cao D; Tang L; Sun C; Hu Y
Int J Lab Hematol; 2016 Dec; 38(6):589-599. PubMed ID: 27870469
[TBL] [Abstract][Full Text] [Related]
10. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.
Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS
Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602
[TBL] [Abstract][Full Text] [Related]
11. The use of circulating microRNAs as diagnostic biomarkers in colorectal cancer.
Clancy C; Joyce MR; Kerin MJ
Cancer Biomark; 2015; 15(2):103-13. PubMed ID: 25547322
[TBL] [Abstract][Full Text] [Related]
12. A plasma microRNA panel for early detection of colorectal cancer.
Wang S; Xiang J; Li Z; Lu S; Hu J; Gao X; Yu L; Wang L; Wang J; Wu Y; Chen Z; Zhu H
Int J Cancer; 2015 Jan; 136(1):152-61. PubMed ID: 23456911
[TBL] [Abstract][Full Text] [Related]
13. The clinical use of circulating microRNAs as non-invasive diagnostic biomarkers for lung cancers.
Yang Y; Hu Z; Zhou Y; Zhao G; Lei Y; Li G; Chen S; Chen K; Shen Z; Chen X; Dai P; Huang Y
Oncotarget; 2017 Oct; 8(52):90197-90214. PubMed ID: 29163821
[TBL] [Abstract][Full Text] [Related]
14. Identification of microRNAs as diagnostic biomarkers in screening of head and neck cancer: a meta-analysis.
Zhang M; Zhao LJ; Liang WQ; Mao ZP
Genet Mol Res; 2015 Dec; 14(4):16562-76. PubMed ID: 26681002
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection.
Chang PY; Chen CC; Chang YS; Tsai WS; You JF; Lin GP; Chen TW; Chen JS; Chan EC
Oncotarget; 2016 Mar; 7(9):10663-75. PubMed ID: 26848774
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic value of microRNA-21 in colorectal cancer: an original study and individual participant data meta-analysis.
Zhang H; Li P; Ju H; Pesta M; Kulda V; Jin W; Cai M; Liu C; Wu H; Xu J; Ye Y; Zhang G; Xu E; Cai J; Lai M; Xia D; Yang J; Wu Y
Cancer Epidemiol Biomarkers Prev; 2014 Dec; 23(12):2783-92. PubMed ID: 25178983
[TBL] [Abstract][Full Text] [Related]
17. The ratio of miR-21/miR-24 as a promising diagnostic and poor prognosis biomarker in colorectal cancer.
Hao JP; Ma A
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8649-8656. PubMed ID: 30575905
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs as noninvasive biomarkers in bladder cancer detection: a diagnostic meta-analysis based on qRT-PCR data.
Xiao S; Wang J; Xiao N
Int J Biol Markers; 2016 Jul; 31(3):e276-85. PubMed ID: 26954073
[TBL] [Abstract][Full Text] [Related]
19. Blood-Based Circulating MicroRNAs are Potential Diagnostic Biomarkers for Leukemia: Result from a Meta-Analysis.
Xu LH; Guo Y; Zhang XL; Chen JJ; Hu SY
Cell Physiol Biochem; 2016; 38(3):939-49. PubMed ID: 26938054
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of interleukin-8 in colorectal cancer: a case-control study and meta-analysis.
Jin WJ; Xu JM; Xu WL; Gu DH; Li PW
World J Gastroenterol; 2014 Nov; 20(43):16334-42. PubMed ID: 25473192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
